Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Abbott (ABT) Stock Moves -1.02%: What You Should Know

Abbott (ABT) closed the most recent trading day at $88.71, moving -1.02% from the previous trading session.

Debanjana Dey headshot

Coronavirus Diagnostic Tests in High Demand: 4 Stocks in Focus

Amid the pandemic, these four companies with strong diagnostics testing developments might show better resilience.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $90.28 in the latest trading session, marking a -0.68% move from the prior day.

Trina Mukherjee headshot

3 MedTech Stocks to Watch Amid Coronavirus Catastrophe

Let's keep a watch on three stocks that have displayed strong performance amid market turmoil led by the ongoing pandemic.

Abbott's Libre 2 iCGM Gets FDA Nod to Better Manage Diabetes

Abbott's (ABT) FDA-cleared FreeStyle Libre 2 iCGM is the only available system to continuously transmit glucose data with real-time alarms.

Abbott's (ABT) FreeStyle Libre Study Outcome Favorable

The latest study outcome aligns with the American Diabetes Association's recommended A1c level of 7% for adults with diabetes.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Abbott (ABT) closed at $89.02, marking a +1.41% move from the previous day.

Sriparna Ghosal headshot

3 Diabetes Management Stocks in the Spotlight Amid Coronavirus

Amid the widespread pandemic crisis, the diabetes management sector continues to thrive on account of multiple positive developments

Trina Mukherjee headshot

Diagnostic Testing Remains Crucial in Combatting Coronavirus

Let's keep a watch on three stocks that are focused on offering advanced diagnostic testing to fight against coronavirus.

Danaher's (DHR) Product Offerings to Aid Amid Pandemic Scares

Danaher's (DHR) risks from pandemic-related uncertainties are evident from weak sales projections for the second quarter. Demand for acute care diagnostics' related products might aid results.

Abbott Stock Down on Urgent Field Safety Notice for TactiCath

Abbott (ABT) also mentions certain guidelines related to product return, reporting, and customer assistance.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $92.62 in the latest trading session, marking a -0.42% move from the prior day.

Abbott (ABT) Gains But Lags Market: What You Should Know

Abbott (ABT) closed at $90.76 in the latest trading session, marking a +1.43% move from the prior day.

Abbott (ABT) Gains As Market Dips: What You Should Know

In the latest trading session, Abbott (ABT) closed at $90.39, marking a +0.33% move from the previous day.

Why Is Abbott (ABT) Down 6.4% Since Last Earnings Report?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Neena Mishra headshot

Healthcare Tech & Robotics ETFs in Focus amid COVID-19 Crisis

The pandemic will forever transform our lives; here are some areas that may benefit.

BJ's Wholesale Club, Polaris Industries, Abbott Laboratories, Eldorado Resorts and Apple highlighted as Zacks Bull and Bear of the Day

BJ's Wholesale Club, Polaris Industries, Abbott Laboratories, Eldorado Resorts and Apple highlighted as Zacks Bull and Bear of the Day

Trina Mukherjee headshot

3 Medical Product Stocks Set to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on several factors.

Neena Mishra headshot

Biotech ETFs Poised to Benefit From Coronavirus

Rising investor interest in coronavirus related stocks will benefit these ETFs

HRC vs. ABT: Which Stock Should Value Investors Buy Now?

HRC vs. ABT: Which Stock Is the Better Value Option?

Tirthankar Chakraborty headshot

3 Stocks Set to Pop Once the Economy Gets Back to Business

We have highlighted three stocks will flourish when the economy reopens. Notably, an increasing number of states are expected to reopen their economies in the first two weeks of May.

The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences

The Zacks Analyst Blog Highlights: Cisco, Abbott Laboratories, NextEra Energy, Gilead Sciences and Edwards Lifesciences

Sheraz Mian headshot

Top Stock Research Reports for Cisco, Abbott, NextEra & Others

Today's Research Daily features new research reports on 16 major stocks, including Cisco (CSCO), Abbott Laboratories (ABT) and NextEra Energy (NEE).

Urmimala Biswas headshot

3 Medical Product Stocks Set to Beat This Earnings Season

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

Sweta Killa headshot

Coronavirus Makes Biotech ETFs Red Hot

The biotech space of the broader healthcare sector is currently the hottest of all segments buoyed by the COVID-19 pandemic.